Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Diego Lanzarot"'
Autor:
Oscar M. Pello, Diego Lanzarot, Mercedes Colorado, Cristina Amunarriz, Andrés Insunza, Lorena Álvarez‐Rodríguez, María Díez de Velasco, Natividad Sainz‐Sainz, José Luis Arroyo
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 2650-2653 (2020)
Abstract Optimization of Hematology Patient's treatment: It is possible to obtain a 100% CD34+ recovery after CD34+ selection using the CliniMACS Prodigy.
Externí odkaz:
https://doaj.org/article/852b13bf86bc428fb51e8993523a3298
Autor:
Estéfani García-Ríos, Alejandra Leivas, Francisco J. Mancebo, Laura Sánchez-Vega, Diego Lanzarot, José María Aguado, Joaquín Martínez-López, María Liz Paciello, Pilar Pérez-Romero
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 630 (2022)
In order to demonstrate the feasibility of preparing clinical-grade SARS-CoV-2-specific T-cells from convalescent donors and the ability of these cells to neutralize the virus in vitro, we used blood collected from two COVID-19 convalescent donors (b
Externí odkaz:
https://doaj.org/article/b5fc443105754a6d9609570248fc0e9c
Autor:
Lucía Fernández, Adrián Fernández, Isabel Mirones, Adela Escudero, Leila Cardoso, María Vela, Diego Lanzarot, Raquel de Paz, Alejandra Leivas, Miguel Gallardo, Antonio Marcos, Ana Belén Romero, Joaquín Martínez-López, Antonio Pérez-Martínez
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Natural killer group 2D (NKG2D) is a natural killer (NK) cell-activating receptor that recognizes different stress-induced ligands that are overexpressed in a variety of childhood and adult tumors. NKG2D chimeric antigen receptor (CAR) T cells have s
Externí odkaz:
https://doaj.org/article/ba4d2ea6112c49d98f6f8eef30f4f95d
Autor:
Lorena Alvarez-Rodriguez, Andrés Insunza, José Luis Arroyo, Diego Lanzarot, Cristina Amunarriz, María Díez de Velasco, Mercedes Colorado, Oscar M Pello, Natividad Sainz-Sainz
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 8, Iss 12, Pp 2650-2653 (2020)
Clinical Case Reports, Vol 8, Iss 12, Pp 2650-2653 (2020)
Optimization of Hematology Patient's treatment: It is possible to obtain a 100% CD34+ recovery after CD34+ selection using the CliniMACS Prodigy.
Autor:
Lucía Fernández, Alfonso Navarro-Zapata, Cristina Ferreras, Diego Lanzarot, Alicia Pernas, Carlos Rodriguez-Antolin, Alejandra Leivas, Marta Cobo, Aurora Viejo, Joaquín Martínez, Gema Casado, Beatriz Ruz-Caracuel, Carmen Mestre, María Vela, Adela Escudero, Isabel Mirones, Nerea Matamala, Adrián Fernández, Antonio Pérez-Martínez
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Cancers
Volume 13
Issue 3
Cancers, Vol 13, Iss 577, p 577 (2021)
Universitat Autònoma de Barcelona
instname
Cancers
Volume 13
Issue 3
Cancers, Vol 13, Iss 577, p 577 (2021)
Universitat Autònoma de Barcelona
Natural killer (NK) cells represent promising tools for cancer immunotherapy. We report the optimization of an NK cell activation–expansion process and its validation on clinical‐scale. Methods: RPMI‐1640, stem cell growth medium (SCGM), NK MAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81a550745a88bb61d650bdae1559978c
https://doi.org/10.3390/cancers13030577
https://doi.org/10.3390/cancers13030577
Autor:
Angelita Rebollo, Diego Lanzarot, Siegmund Fischer, Carlos Martínez-A, Ana Cerezo, Thomas F. Franke
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
El copyright pertenece a The American Society for Cell Biology. The final versión of the paper is available at http://www.pubmedcentral.nih.gov
We have shown previously that interleukin-4 (IL-4) protects TS1ab cells from apoptosis, but very lit
We have shown previously that interleukin-4 (IL-4) protects TS1ab cells from apoptosis, but very lit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4573b8f2907f2cd3eb57d18a27954881
http://hdl.handle.net/10261/3467
http://hdl.handle.net/10261/3467